Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 5384091, 9 pages
https://doi.org/10.1155/2017/5384091
Research Article

Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma

1Department of Clinical Laboratory Medicine, Cancer Hospital, Shantou University Medical College, Shantou 515041, China
2Department of Biochemistry and Molecular Biology, Shantou University Medical College, Shantou 515041, China
3The Key Laboratory of Molecular Biology for High Cancer Incidence Coastal Chaoshan Area of Guangdong Higher Education Institutes, Shantou University Medical College, Shantou 515041, China
4Shantou University Medical College, Shantou 515041, China
5Department of Radiation Oncology, Cancer Hospital, Shantou University Medical College, Shantou 515041, China
6Department of Oncological Research Laboratory, Cancer Hospital, Shantou University Medical College, Shantou 515041, China
7Department of Surgical Oncology, Cancer Hospital, Shantou University Medical College, Shantou 515041, China
8Institute of Oncologic Pathology, Shantou University Medical College, Shantou 515041, China

Correspondence should be addressed to Yu-Hui Peng; moc.361@666iuhuygnep and En-Min Li; nc.ude.uts@ilmn

Received 9 May 2017; Revised 10 July 2017; Accepted 16 July 2017; Published 9 August 2017

Academic Editor: Stamatios E. Theocharis

Copyright © 2017 Yi-Wei Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Global Burden of Disease Cancer Collaboration, C. Fitzmaurice, D. Dicker et al., “The global burden of cancer 2013,” JAMA Oncology, vol. 1, no. 4, pp. 505–527, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Chen, R. Zheng, P. D. Baade et al., “Cancer statistics in China, 2015,” CA: A Cancer Journal for Clinicians, vol. 66, no. 2, pp. 115–132, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Hiripi, L. Jansen, A. Gondos et al., “Survival of stomach and esophagus cancer patients in Germany in the early 21st century,” Acta Oncologica, vol. 51, no. 7, pp. 906–914, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Q. Wang, G. G. Jiao, F. B. Chang et al., “Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening,” The Annals of Thoracic Surgery, vol. 77, no. 5, pp. 1740–1744, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Mealy, J. Feely, I. Reid, J. McSweeney, T. Walsh, and T. P. Hennessy, “Tumour marker detection in oesophageal carcinoma,” European Journal of Surgical Oncology, vol. 22, no. 5, pp. 505–507, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Shimada, Y. Nabeya, S. Okazumi et al., “Prognostic significance of CYFRA 21-1 in patients with esophageal squamous cell carcinoma,” Journal of the American College of Surgeons, vol. 196, no. 4, pp. 573–578, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Kosugi, T. Nishimaki, T. Kanda, S. Nakagawa, M. Ohashi, and K. Hatakeyama, “Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients,” World Journal of Surgery, vol. 28, no. 7, pp. 680–685, 2004. View at Publisher · View at Google Scholar
  9. E. M. Tan and J. Zhang, “Autoantibodies to tumor-associated antigens: reporters from the immune system,” Immunological Reviews, vol. 222, pp. 328–340, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. X. Shi, J. J. Qin, H. Ye, P. Wang, K. J. Wang, and J. Y. Zhang, “Tumor associated antigens or anti-TAA autoantibodies as biomarkers in the diagnosis of ovarian cancer: a systematic review with meta-analysis,” Expert Review of Molecular Diagnostics, vol. 15, no. 6, pp. 829–852, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Liu, B. Peng, Y. Lu, W. Xu, W. Qian, and J. Y. Zhang, “Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis,” Autoimmunity Reviews, vol. 10, no. 6, pp. 331–335, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. C. M. Nicolet and E. A. Craig, “Isolation and characterization of STI1, a stress-inducible gene from Saccharomyces cerevisiae,” Molecular and Cellular Biology, vol. 9, no. 9, pp. 3638–3646, 1989. View at Publisher · View at Google Scholar
  13. O. O. Odunuga, V. M. Longshaw, and G. L. Blatch, “Hop: more than an Hsp70/Hsp90 adaptor protein,” BioEssays, vol. 26, no. 10, pp. 1058–1068, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. A. B. Schmid, S. Lagleder, M. A. Gräwert et al., “The architecture of functional modules in the Hsp90 co-chaperone Sti1/Hop,” The EMBO Journal, vol. 31, no. 6, pp. 1506–1517, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Kubota, S. Yamamoto, E. Itoh et al., “Increased expression of co-chaperone HOP with HSP90 and HSC70 and complex formation in human colonic carcinoma,” Cell Stress & Chaperones, vol. 15, no. 6, pp. 1003–1011, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Walsh, N. O'Donovan, S. Kennedy et al., “Identification of pancreatic cancer invasion-related proteins by proteomic analysis,” Proteome Science, vol. 7, p. 3, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Padden, D. A. Megger, T. Bracht et al., “Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma,” Molecular & Cellular Proteomics, vol. 13, no. 10, pp. 2661–2672, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Cho, S. Kim, H. Y. Shin et al., “Expression of stress-induced phosphoprotein1 (STIP1) is associated with tumor progression and poor prognosis in epithelial ovarian cancer,” Genes, Chromosomes & Cancer, vol. 53, no. 4, pp. 277–288, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Chao, C. H. Lai, C. L. Tsai et al., “Tumor stress-induced phosphoprotein1 (STIP1) as a prognostic biomarker in ovarian cancer,” PloS One, vol. 8, no. 2, article e57084, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. M. J. Scanlan, J. D. Gordan, B. Williamson et al., “Antigens recognized by autologous antibody in patients with renal-cell carcinoma,” International Journal of Cancer, vol. 83, no. 4, pp. 456–464, 1999. View at Publisher · View at Google Scholar
  21. S. Kim, H. Cho, E. J. Nam et al., “Autoantibodies against stress-induced phosphoprotein-1 as a novel biomarker candidate for ovarian cancer,” Genes, Chromosomes & Cancer, vol. 49, no. 7, pp. 585–595, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. W. Xu, Y. H. Peng, B. Chen et al., “Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma,” The American Journal of Gastroenterology, vol. 109, no. 1, pp. 36–45, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Li, M. Liu, J. B. Lin et al., “Diagnostic value of autoantibodies against ezrin in esophageal squamous cell carcinoma,” Disease Markers, vol. 2017, Article ID 2534648, 6 pages, 2017. View at Publisher · View at Google Scholar
  24. T. W. Rice, E. H. Blackstone, and V. W. Rusch, “7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction,” Annals of Surgical Oncology, vol. 17, no. 7, pp. 1721–1724, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. H. Peng, Y. W. Xu, L. S. Huang et al., “Autoantibody signatures combined with Epstein-Barr virus capsid antigen-IgA as a biomarker panel for the detection of nasopharyngeal carcinoma,” Cancer Prevention Research, vol. 8, no. 8, pp. 729–736, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Q. Wei, Z. F. Chen, Y. T. He et al., “Long-term follow-up of a community assignment, one-time endoscopic screening study of esophageal cancer in China,” Journal of Clinical Oncology, vol. 33, no. 17, pp. 1951–1957, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Shiku, T. Takahashi, L. A. Resnick, H. F. Oettgen, and L. J. Old, “Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics,” The Journal of Experimental Medicine, vol. 145, no. 3, pp. 784–789, 1977. View at Publisher · View at Google Scholar
  28. X. Wang, J. Yu, A. Sreekumar et al., “Autoantibody signatures in prostate cancer,” The New England Journal of Medicine, vol. 353, no. 12, pp. 1224–1235, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. K. S. Anderson, D. W. Cramer, S. Sibani et al., “Autoantibody signature for the serologic detection of ovarian cancer,” Journal of Proteome Research, vol. 14, no. 1, pp. 578–586, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. H. Peng, Y. W. Xu, H. Guo et al., “Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma,” Cancer Medicine, vol. 5, no. 7, pp. 1388–1396, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Lam, P. Boyle, G. F. Healey et al., “EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer,” Cancer Prevention Research, vol. 4, no. 7, pp. 1126–1134, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. C. J. Chapman, G. F. Healey, A. Murray et al., “EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays,” Tumour Biology, vol. 33, no. 5, pp. 1319–1326, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. H. F. Zhang, J. J. Qin, P. F. Ren et al., “A panel of autoantibodies against multiple tumor-associated antigens in the immunodiagnosis of esophageal squamous cell cancer,” Cancer Immunology, Immunotherapy, vol. 65, no. 10, pp. 1233–1242, 2016. View at Publisher · View at Google Scholar · View at Scopus
  34. W. X. Chen, X. B. Hong, C. Q. Hong et al., “Tumor-associated autoantibodies against ascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma,” Clinics and Research in Hepatology and Gastroenterology, vol. 41, no. 3, pp. 327–332, 2017. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. W. Xu, Y. H. Peng, L. Q. Ran et al., “Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma,” Clinical & Translational Oncology, vol. 19, no. 7, pp. 898–906, 2017. View at Publisher · View at Google Scholar
  36. H. T. Tan, J. Low, S. G. Lim, and M. C. Chung, “Serum autoantibodies as biomarkers for early cancer detection,” The FEBS Journal, vol. 276, no. 23, pp. 6880–6904, 2009. View at Publisher · View at Google Scholar · View at Scopus